Reviparin sodium
Reviparin sodium is a low molecular weight heparin (LMWH) that is primarily used as an anticoagulant for the prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE). It is a derivative of heparin, a naturally occurring anticoagulant produced by basophils and mast cells.
Pharmacology[edit]
Reviparin sodium works by enhancing the inhibition of Factor Xa and thrombin by increasing antithrombin III activity. This prevents the conversion of fibrinogen to fibrin, thereby inhibiting blood clot formation. It has a higher ratio of anti-Factor Xa to anti-thrombin activity compared to unfractionated heparin, which may contribute to its superior efficacy and safety profile.
Clinical Use[edit]
Reviparin sodium is indicated for the prevention of DVT and PE in patients undergoing orthopedic or abdominal surgery, and in acutely ill medical patients at risk for thromboembolic complications. It is also used for the treatment of acute DVT and PE, and for the prevention of clotting in the extracorporeal circulation during hemodialysis.
Side Effects[edit]
The most common side effect of reviparin sodium is bleeding. Other side effects may include thrombocytopenia, hypersensitivity reactions, and, rarely, osteoporosis with long-term use.
Contraindications[edit]
Reviparin sodium is contraindicated in patients with active major bleeding, severe thrombocytopenia, or known hypersensitivity to reviparin sodium or to any of its components. It should be used with caution in patients with a high risk of bleeding, such as those with severe hypertension, peptic ulcer disease, or recent brain, spinal, or ophthalmic surgery.
Dosage and Administration[edit]
The dosage of reviparin sodium is individualized based on the patient's weight, indication, and renal function. It is administered subcutaneously, usually once or twice daily.
See Also[edit]
- Low molecular weight heparin
- Anticoagulant
- Deep vein thrombosis
- Pulmonary embolism
- Heparin
- Factor Xa
- Thrombin
- Fibrin
- Hemodialysis
- Thrombocytopenia
- Osteoporosis
Reviparin_sodium[edit]
-
Heparin General Structure
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
